Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
Product Unit Size | Cost | Quantity | Stock |
---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
Cas No. | 1258595-14-0 |
---|---|
Purity | ≥99% |
Formula | C29H32F2N3O7P |
Formula Wt. | 603.56 |
IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
Synonym | LHC165 |
Appearance | Pale yellow powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
Endogenous adhesion molecule, binds PKC, calmod...
Polyanionic sulfated glycosaminoglycan, encogen...
Peptide; α4β1 integrin activator.
Tamoxifen derivative; potential proteasome inhi...
Inhibitor of Bruton’s tyrosine kinase (BTK).<...
Nucleoside (thymidine) analog; DNA chain termin...
Diterpene antibiotic produced by Cephalosporum;...
Pyrimidine analog; inhibits thymidylate synthas...
benzophenanthridine alkaloid found in Chelidoni...
Endogenous tachykinin peptide, involved in infl...
Benzoquinone ansamycin; topoisomerase VI-B, HSP...
Sulfonamide; folic acid synthesis inhibitor.
Glycylcycline; protein synthesis inhibitor.
5-HT3 antagonist.
σ2 agonist.
D2 and 5-HT1A partial agonist, 5-HT2C/6/7 antag...
CDK4/6 inhibitor.
Nucleoside (guanosine) analog; DNA chain termin...
Peptide, IgG derivative, tuftsin analog.
Mycotoxin produced by Alternaria; topoisomerase...